Jerzy Jankun, DSc, PhD
Jerzy Jankun, DSc, PhD
Professor, Department of Urology, The University of Toledo
Verified email at
Cited by
Cited by
Why drinking green tea could prevent cancer
J Jankun, SH Selman, R Swiercz, E Skrzypczak-Jankun
Nature 387, 561, 1997
Curcumin inhibits lipoxygenase by binding to its central cavity: theoretical and X-ray evidence.
E Skrzypczak-Jankun, NP McCabe, SH Selman, J Jankun
International journal of molecular medicine 6 (5), 521-527, 2000
In vivo and in vitro effect of baicalein on human prostate cancer cells.
R Miocinovic, NP McCabe, RW Keck, J Jankun, JA Hampton, SH Selman
International journal of oncology 26 (1), 241-246, 2005
Inhibitors of urokinase reduce size of prostate cancer xenografts in severe combined immunodeficient mice
J Jankun, RW Keck, E Skrzypczak-Jankun, R Swiercz
Cancer Research 57 (4), 559-563, 1997
Expression and localization of elements of the plasminogen activation system in benign breast disease and breast cancers
J Jankun, HW Merrick, PJ Goldblatt
Journal of cellular biochemistry 53 (2), 135-144, 1993
A study of the anti-diabetic agents of camel milk
A Malik, A Al-Senaidy, E Skrzypczak-Jankun, J Jankun
International journal of molecular medicine 30 (3), 585-592, 2012
Structure of curcumin in complex with lipoxygenase and its significance in cancer
E Skrzypczak-Jankun, K Zhou, NP McCabe, SH Selman, J Jankun
International journal of molecular medicine 12, 17-24, 2003
2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin causes increases in expression of c-erb-A and levels of protein-tyrosine kinases in selected tissues of responsive mouse strains
DW BoMBICK, J Jankun, K Tullis, F Matsumura
Proceedings of the National Academy of Sciences 85 (12), 4128, 1988
Inhibition of lipoxygenase by (-)-epigallocatechin gallate: X-ray analysis at 2.1 reveals degradation of EGCG and shows soybean LOX-3 complex with EGC instead
E Skrzypczak-Jankun, K Zhou, J Jankun
Int. J. Mol. Med 12, 415-422, 2003
Lipoxygenase interactions with natural flavonoid, quercetin, reveal a complex with protocatechuic acid in its X‐ray structure at 2.1 resolution
OY Borbulevych, J Jankun, SH Selman, E Skrzypczak‐Jankun
Proteins: structure, function, and bioinformatics 54 (1), 13-19, 2004
Plasminogen activator inhibitor-1 in kidney pathology
S Małgorzewicz, E Skrzypczak-Jankun, J Jankun
International journal of molecular medicine 31 (3), 503-510, 2013
Determining whether curcumin degradation/condensation is actually bioactivation
J Jankun, M Wyganowska-Świątkowska, K Dettlaff, A Jelińska, ...
International journal of molecular medicine 37 (5), 1151-1158, 2016
Molecular basis of specific inhibition of urokinase plasminogen activator by amiloride.
J Jankun, E Skrzypczak-Jankun
Cancer biochemistry biophysics 17 (1-2), 109-123, 1999
Angiostatic activity of synthetic inhibitors of urokinase type plasminogen activator
R Swiercz, E Skrzypczak-Jankun, MM Merrell, SH Selman, J Jankun
Oncology reports 6, 523-526, 1999
Human platelet 12-lipoxygenase, new findings about its activity, membrane binding and low-resolution structure
AM Aleem, J Jankun, JD Dignam, M Walther, H Khn, DI Svergun, ...
Journal of molecular biology 376 (1), 193-209, 2008
Plasminogen activator inhibitor type-1: its structure, biological activity and role in tumorigenesis
J Chorostowska-Wynimko, E Skrzypczak-Jankun, J Jankun
Int J Mol Med 13 (6), 759-766, 2004
Recombinant PAI-1 inhibits angiogenesis and reduces size of LNCaP prostate cancer xenografts in SCID mice
R Swiercz, RW Keck, E Skrzypczak-Jankun, SH Selman, J Jankun
Oncology reports 8 (3), 463-470, 2001
Synthetic curcuminoids modulate the arachidonic acid metabolism of human platelet 12-lipoxygenase and reduce sprout formation of human endothelial cells
J Jankun, AM Aleem, S Malgorzewicz, M Szkudlarek, MI Zavodszky, ...
Molecular cancer therapeutics 5 (5), 1371, 2006
Expression of soluble urokinase plasminogen activator receptor may be related to outcome in prostate cancer patients.
NP McCabe, FF Angwafo, A Zaher, SH Selman, A Kouinche, J Jankun
Oncology reports 7 (4), 879-961, 2000
A Novel Form of the Plasminogen Activator Inhibitor Created by Cysteine Mutations Extends Its Half-Life: Relevance to Cancer and Angiogenesis1
J Chorostowska-Wynimko, R Swiercz, E Skrzypczak-Jankun, A Wojtowicz, ...
Molecular cancer therapeutics 2 (1), 19, 2003
The system can't perform the operation now. Try again later.
Articles 1–20